BILINSKY IGOR has filed 76 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 117500 shares of IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 117500 | $0.00 | 117,500.0000 | 357,345 | 9999.99% | 32.88% |
| March 5, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 31246 | $0.00 | 142,394.0000 | 357,345 | 28.11% | 8.74% |
| March 5, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 16628 | $4.58 | 125,766.0000 | 357,345 | 11.68% | 4.65% |
| March 5, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 31246 | $0.00 | 62,504.0000 | 357,345 | 33.33% | 8.74% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 6903 | $3.79 | 111,148.0000 | 357,345 | 5.85% | 1.93% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8790 | $0.00 | 35,159.0000 | 357,345 | 20.00% | 2.46% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3517 | $0.00 | 0.0000 | 357,345 | 100.00% | 0.98% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 12307 | $0.00 | 118,051.0000 | 357,345 | 11.64% | 3.44% |
| Dec. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 3,517.0000 | 334,511 | 49.99% | 1.05% |
| Dec. 1, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 4464 | $2.23 | 104,014.0000 | 334,511 | 4.12% | 1.33% |
| Dec. 1, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 8789 | $0.00 | 108,478.0000 | 334,511 | 8.82% | 2.63% |
| Dec. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 107,530.0000 | 334,511 | 3.38% | 1.05% |
| Dec. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1786 | $2.14 | 105,744.0000 | 334,511 | 1.66% | 0.53% |
| Dec. 1, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8789 | $0.00 | 43,949.0000 | 334,511 | 16.67% | 2.63% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8790 | $0.00 | 52,738.0000 | 334,511 | 14.29% | 2.63% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 6250 | $2.19 | 99,689.0000 | 334,511 | 5.90% | 1.87% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 12306 | $0.00 | 105,939.0000 | 334,511 | 13.14% | 3.68% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 7,033.0000 | 334,511 | 33.33% | 1.05% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 6250 | $1.76 | 93,633.0000 | 322,868 | 6.26% | 1.94% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 12305 | $0.00 | 99,883.0000 | 322,868 | 14.05% | 3.81% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8789 | $0.00 | 61,528.0000 | 322,868 | 12.50% | 2.72% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 10,549.0000 | 322,868 | 25.00% | 1.09% |
| March 5, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 289,877 | 9999.99% | 32.34% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 33302 | $4.04 | 87,578.0000 | 289,877 | 27.55% | 11.49% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 62106 | $0.00 | 120,880.0000 | 289,877 | 105.67% | 21.43% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 58590 | $0.00 | 70,317.0000 | 289,877 | 45.45% | 20.21% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 14,065.0000 | 289,877 | 20.00% | 1.21% |
| Jan. 14, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 60,352.0000 | 289,877 | 4.89% | 0.97% |
| Jan. 14, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1578 | $5.89 | 58,774.0000 | 289,877 | 2.61% | 0.54% |
| Jan. 14, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 0.0000 | 289,877 | 100.00% | 0.97% |
| Dec. 2, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 59,323.0000 | 303,269 | 6.30% | 1.16% |
| Dec. 2, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 17,581.0000 | 303,269 | 16.67% | 1.16% |
| Dec. 2, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1784 | $9.07 | 57,539.0000 | 303,269 | 3.01% | 0.59% |
| Oct. 14, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 2,813.0000 | 303,269 | 50.00% | 0.93% |
| Oct. 14, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1428 | $9.77 | 55,807.0000 | 303,269 | 2.49% | 0.47% |
| Oct. 14, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 57,235.0000 | 303,269 | 5.17% | 0.93% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 21,097.0000 | 284,817 | 14.29% | 1.23% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 44,659.0000 | 284,817 | 8.55% | 1.23% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1784 | $10.85 | 42,875.0000 | 284,817 | 3.99% | 0.63% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 23438 | $0.00 | 66,313.0000 | 284,817 | 54.67% | 8.23% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 11891 | $10.85 | 54,422.0000 | 284,817 | 17.93% | 4.18% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 23438 | $0.00 | 23,437.0000 | 284,817 | 50.00% | 8.23% |
| July 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 42,571.0000 | 284,817 | 7.08% | 0.99% |
| July 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1428 | $8.68 | 41,143.0000 | 284,817 | 3.35% | 0.50% |
| July 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 5,626.0000 | 284,817 | 33.33% | 0.99% |
| June 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1784 | $8.37 | 39,758.0000 | 266,220 | 4.29% | 0.67% |
| June 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 41,542.0000 | 266,220 | 9.25% | 1.32% |
| June 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 24,613.0000 | 266,220 | 12.50% | 1.32% |
| April 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1427 | $11.89 | 38,026.0000 | 266,220 | 3.62% | 0.54% |
| April 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2812 | $0.00 | 39,453.0000 | 266,220 | 7.67% | 1.06% |
| April 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2812 | $0.00 | 8,439.0000 | 266,220 | 24.99% | 1.06% |
| March 4, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 14061 | $0.00 | 28,129.0000 | 235,131 | 33.33% | 5.98% |
| March 4, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 14061 | $0.00 | 43,928.0000 | 235,131 | 47.08% | 5.98% |
| March 4, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 7287 | $16.96 | 36,641.0000 | 235,131 | 16.59% | 3.10% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 105470 | $0.00 | 105,470.0000 | 235,131 | 9999.99% | 44.86% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 235,131 | 9999.99% | 19.94% |
| Jan. 16, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 11,251.0000 | 235,131 | 20.00% | 1.20% |
| Jan. 16, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 31,444.0000 | 235,131 | 9.83% | 1.20% |
| Jan. 16, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1577 | $8.37 | 29,867.0000 | 235,131 | 5.02% | 0.67% |
| Oct. 16, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1395 | $3.57 | 28,631.0000 | 245,817 | 4.65% | 0.57% |
| Oct. 16, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 30,026.0000 | 245,817 | 10.34% | 1.14% |
| Oct. 16, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 14,064.0000 | 245,817 | 16.67% | 1.14% |
| July 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 16,877.0000 | 224,481 | 14.29% | 1.25% |
| July 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1395 | $7.76 | 27,213.0000 | 224,481 | 4.88% | 0.62% |
| July 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 28,608.0000 | 224,481 | 10.91% | 1.25% |
| April 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2812 | $0.00 | 19,690.0000 | 213,694,000 | 12.50% | 0.00% |
| April 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1395 | $5.64 | 25,795.0000 | 213,694,000 | 5.13% | 0.00% |
| April 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2812 | $0.00 | 27,190.0000 | 213,694,000 | 11.53% | 0.00% |
| March 2, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 42190 | $0.00 | 42,190.0000 | 159,259 | 9999.99% | 26.49% |
| March 2, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | A | Stock Option (right to buy) | 84380 | $0.00 | 84,380.0000 | 159,259 | 9999.99% | 52.98% |
| Jan. 17, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 11248 | $0.00 | 22,502.0000 | 159,259 | 33.33% | 7.06% |
| Jan. 17, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 4671 | $6.43 | 24,378.0000 | 159,259 | 16.08% | 2.93% |
| Jan. 17, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 11248 | $0.00 | 29,049.0000 | 159,259 | 63.19% | 7.06% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 10553 | $6.11 | 17,801.0000 | 159,259 | 37.22% | 6.63% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 18850 | $0.00 | 28,354.0000 | 159,259 | 198.34% | 11.84% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 18850 | $0.00 | 0.0000 | 159,259 | 100.00% | 11.84% |